Antisense RNA and DNA molecules as tools for gene inhibitionAMMENDOLA, S; CIPOLLARO, M; CASCINO, A et al.Chimica oggi. 1991, Vol 9, Num 7-8, pp 17-22, issn 0392-839XArticle

Mécanismes de l'inhibition in vitro de la traduction et de la transcription inverse par des olignonucléotides antisens = Mechanisms of in vitro inhibition of translation and reverse transcription by antisense oligonucleotidesBoiziau, Claudine; Ascher, Philippe.1991, 183 p.Thesis

Contribution à l'étude de la région 5' non-codante de l'ARN du virus Y de la pomme de terre = Preliminary studies on the 5' non-translated region of potato virus Y RNALevis, Caroline; Dron, Michel.1992, 286 p.Thesis

«Synthèse d'oligonucléotides chimériques: 2ʹ,5ʹ-oligoadénylate d'anomérie alpha et L-oligodéoxynucléotides = «Synthesis of chimeric oligonucleotides: alpha anomeric 2ʹ,5ʹ-oligoadenylates and L-oligodeoxynucleotidesFolcrand, Géraldine; Rayner, Bernard.1992, 198 p.Thesis

Stability and properties of double and triple helices : dramatic effects of RNA or DNA backbone compositionROBERTS, R. W; CROTHERS, D. M.Science (Washington, D.C.). 1992, Vol 258, Num 5087, pp 1463-1466, issn 0036-8075Article

Oligonucléotidesantisens. Nouveaux agents thérapeutiques? = Antisense oligonucleotides. New therapeutic agents?TOLOU, H.Médecine et armées. 1992, Vol 20, Num 8, pp 675-678, issn 0300-4937Article

Differentiation of HL-60 leukemia by type I regulatory subunite antisense oligodeoxynucleotide of cAMP-dependent protein kinaseTORTORA, G; YOKOZAKI, H; PEPE, S et al.Proceedings of the National Academy of Sciences of the United States of America. 1991, Vol 88, Num 5, pp 2011-2015, issn 0027-8424, 5 p.Article

Oct-3 is a maternal factor required for the first mouse embryonic divisionROSNER, M. H; DE SANTO, R. J; ARNHEITER, H et al.Cell (Cambridge). 1991, Vol 64, Num 6, pp 1103-1110, issn 0092-8674, 8 p.Article

Inhibition of SV40 gene expression by microinjected small antisense RNA and DNA moleculesGRAESSMANN, M; MICHAELS, G; BERG, B et al.Nucleic acids research. 1991, Vol 19, Num 1, pp 53-59, issn 0305-1048, 7 p.Article

Reactive oligonucleotide derivatives as gene-targeted biologically active compounds and affinity probesKNORRE, D. G; VLASSOV, V. V.Genetica ('s-Gravenhage). 1991, Vol 85, Num 1, pp 53-63, issn 0016-6707Article

Papers presented/EMBO/INSERM workshop on regulation of gene expression by RNA structure and anti-messengersTOULME, J.-J; KRISCH, H. H; VON GABAIN, A et al.Gene (Amsterdam). 1988, Vol 72, Num 1-2, issn 0378-1119, 371 p.Conference Proceedings

Antisense oligonucleotides for central nervous system tumorsHALL, W. A; FLORES, E. P; LOW, W. C et al.Neurosurgery. 1996, Vol 38, Num 2, pp 376-383, issn 0148-396XArticle

Biodegradable poly(L-lactic acid) matrices for the sustained delivery of antisense oligonucleotidesLEWIS, K. J; IRWIN, W. J; AKHTAR, S et al.Journal of controlled release. 1995, Vol 37, Num 1-2, pp 173-183, issn 0168-3659Article

Selective amplification techniques for optimization of ribozyme functionJOYCE, G. F.Modern cell biology. 1992, Vol 11, pp 353-372, issn 0745-3000Article

Modulation of multidrug resistance gene (mdr-I) with antisense oligodeoxynucleotidesLIU, C; QURESHI, I. A; DING, X.-J et al.Clinical science (1979). 1996, Vol 91, Num 1, pp 93-98, issn 0143-5221Conference Paper

Inhibition of thymidine kinase gene expression by anti-sense RNA: a molecular approach to genetic analysisIZANT, J. G; WEINTRAUB, H.Cell (Cambridge). 1984, Vol 36, Num 4, pp 1007-1015, issn 0092-8674Article

Utilisation des thérapeutiques ciblées en onco-dermatologie : Onco-dermatologie = Targeted therapies in oncodermatologyKEROB, D; LEBBE, C.La Lettre du cancérologue (Boulogne). 2009, Vol 18, Num 2, pp 90-95, issn 1165-113X, 6 p.Article

Antisense anti-IGF-I therapy of primary hepatic cancer = Thérapie du carcinome hépatique primaire par approche antisens anti-IGF-ITROJAN, L. A; LY, A; KULIG, J et al.Journal africain du cancer (Print). 2009, Vol 1, Num 1, pp 21-30, issn 1965-0817, 10 p.Article

Antisense therapy for malignant diseaseO'BRIEN, S. G; KIRKLAND, M. A; GOLDMAN, J. M et al.European journal of cancer. Part A. 1994, Vol 30, Num 8, pp 1160-1164Article

Anti-sense peptide recognition of sense peptides: direct quantitative characterization with the ribonuclease S-peptide system using analytical characterization with the ribonuclease S-peptide system using analytical high-performance affinity chromatographySHAI, Y; FLASHNER, M; CHAIKEN, I. M et al.Biochemistry (Easton). 1987, Vol 26, Num 3, pp 669-675, issn 0006-2960Article

Use of antisense nucleic acids : an introductionMALCOLM, A. D. B.Biochemical Society transactions. 1992, Vol 20, Num 4, pp 745-746, issn 0300-5127Conference Paper

Preparation and hybridization properties of oligonucleotides containing 1-α-D-arabinofuranosylthymineADAMS, A. D; PETRIE, C. R; MEYER, R. B et al.Nucleic acids research. 1991, Vol 19, Num 13, pp 3647-3651, issn 0305-1048Article

Synthèse et étude d'analogues oligonucléosidiques antisens à caractère non-ionique: méthylphosphotriesters, N-alkoxyphosphoramidates, phosphoramidates = Synthesis and study of non-ionic antisense oligonucleosides analogs: methylphosphotriesters, N-alkoxyphosphoramidates, phosphoramidatesPeyrottes, Suzanne; Vasseur, J.-J.1995, 196 p.Thesis

Antisense and antigene properties of peptide nucleic acidsHANVEY, J. C; PEFFER, N. J; CARTER, S. G et al.Science (Washington, D.C.). 1992, Vol 258, Num 5087, pp 1481-1485, issn 0036-8075Article

Antisense strategies and therapeutic applicationsPUTNAM, D. A.American journal of health-system pharmacy. 1996, Vol 53, Num 2, pp 151-160, issn 1079-2082Article